PEDIAMYCIN 400 Drug Patent Profile
When do Pediamycin 400 patents expire, and what generic alternatives are available?
Pediamycin 400 is a drug marketed by Arbor Pharms Llc and is included in one NDA.
The generic ingredient in PEDIAMYCIN 400 is erythromycin ethylsuccinate. There is one drug master file entry for this compound. Ten suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pediamycin 400
A generic version of PEDIAMYCIN 400 was approved as erythromycin ethylsuccinate by CARNEGIE on December 31st, 1969.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PEDIAMYCIN 400?
- What are the global sales for PEDIAMYCIN 400?
- What is Average Wholesale Price for PEDIAMYCIN 400?
Summary for PEDIAMYCIN 400
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 68 |
| Patent Applications: | 1,958 |
| DailyMed Link: | PEDIAMYCIN 400 at DailyMed |
US Patents and Regulatory Information for PEDIAMYCIN 400
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Arbor Pharms Llc | PEDIAMYCIN 400 | erythromycin ethylsuccinate | SUSPENSION;ORAL | 062304-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
